Refreshing results…
Formate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade
UploadPublisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
UploadTargeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
UploadCombined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial
UploadOncometabolite d -2HG alters T cell metabolism to impair CD8 + T cell function
UploadSingle-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
UploadUnderstanding adverse events of immunotherapy: A mechanistic perspective
Download from rupress.orgPD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
Download from www.nature.comPTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
Download from www.nature.comRescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Download from www.ncbi.nlm.nih.govMissing publications? Search for publications with a matching author name.